Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer

被引:0
|
作者
Rugo, Hope S. [1 ,2 ]
机构
[1] UCSF Helen Diller Family Comprehens Canc Ctr, Med, San Francisco, CA 94158 USA
[2] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol & Clin Trials Educ, San Francisco, CA 94158 USA
关键词
RECURRENCE; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:596 / 599
页数:4
相关论文
共 50 条
  • [1] Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
    Schlam, Ilana
    Corti, Chiara
    Sammons, Sarah
    Mittendorf, Elizabeth A.
    Tolaney, Sara M.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 511 - 520
  • [2] Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer
    O'Regan, Ruth M.
    Zhang, Yi
    Fleming, Gini F.
    Francis, Prudence A.
    Kammler, Roswitha
    Viale, Giuseppe
    Dell'Orto, Patrizia
    Lang, Istvan
    Bellet, Meritxell
    Bonnefoi, Herve R.
    Tondini, Carlo
    Villa, Federica
    Bernardo, Antonio
    Ciruelos, Eva M.
    Neven, Patrick
    Karlsson, Per
    Mueller, Bettina
    Jochum, Wolfram
    Zaman, Khalil
    Martino, Silvana
    Geyer, Charles E.
    Jerzak, Katarzyna J.
    Davidson, Nancy E.
    Coleman, Robert E.
    Ingle, James N.
    van Mackelenbergh, Marion T.
    Loi, Sherene
    Colleoni, Marco
    Schnabel, Catherine A.
    Treuner, Kai
    Regan, Meredith M.
    [J]. JAMA ONCOLOGY, 2024,
  • [3] Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer
    Jerez, Yolanda
    Herrero, Blanca
    Arregui, Marta
    Moron, Blanca
    Martin, Miguel
    Echavarria, Isabel
    [J]. FUTURE ONCOLOGY, 2020, 16 (17) : 1165 - 1177
  • [4] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Nayyar, Apoorve
    Strassle, Paula D.
    Iles, Kathleen
    Jameison, Danielle
    Jadi, Jihane
    McGuire, Kandace P.
    Gallagher, Kristalyn K.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4853 - 4860
  • [5] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Apoorve Nayyar
    Paula D. Strassle
    Kathleen Iles
    Danielle Jameison
    Jihane Jadi
    Kandace P. McGuire
    Kristalyn K. Gallagher
    [J]. Annals of Surgical Oncology, 2020, 27 : 4853 - 4860
  • [6] Locoregional Therapy Patterns in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer
    Nguyen, Kenny
    Hersh, Eliza H.
    Chen, Yu-Jen
    King, Tari
    Mittendorf, Elizabeth
    Minami, Christina A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S87 - S88
  • [7] Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer
    Downs-Canner, Stephanie M.
    Gaber, Charles E.
    Louie, Raphael J.
    Strassle, Paula D.
    Gallagher, Kristalyn K.
    Muss, Hyman B.
    Ollila, David W.
    [J]. CANCER, 2020, 126 (06) : 1193 - 1201
  • [8] Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer
    Warren, Stephanie L.
    Bhutiani, Neal
    Agle, Steven C.
    Martin, Robert C. G., II
    McMasters, Kelly M.
    Ajkay, Nicolas
    [J]. AMERICAN JOURNAL OF SURGERY, 2018, 216 (02): : 326 - 330
  • [9] The Close Relationship Between Metabolic Syndrome and Hormone Receptor-Positive Early-Stage Breast Cancer
    Ozveren, Ahmet
    Ridvanogullari Donger, Melis
    Motor, Sedat
    Bulut, Gulcan
    [J]. INTEGRATIVE CANCER THERAPIES, 2023, 22
  • [10] The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer
    Jain, Sarika
    Santa-Maria, Cesar Augusto
    Gradishar, William J.
    [J]. ONCOLOGY-NEW YORK, 2015, 29 (07): : 473 - +